Effects of pegylated interferon α2b on metastasis of hepatocellular carcinoma.

[1]  T. Sauerbruch,et al.  Plasminogen fragment K1–3 inhibits expression of adhesion molecules and experimental HCC recurrence in the liver , 2009, International Journal of Colorectal Disease.

[2]  H. Miyake,et al.  Effect of a new adjuvant systemic interferon alpha, 5-fluorouracil and cisplatin on advanced hepatocellular carcinoma with macroscopic portal invasion. , 2008, Hepato-gastroenterology.

[3]  Jun-Sung Kim,et al.  Serum immunoglobulin fused interferon-α inhibited tumor growth in athymic mice bearing colon 26 adenocarcinoma cells , 2008, Journal of Veterinary Science.

[4]  M. Kuwano,et al.  Growth inhibitory effects of pegylated IFN α‐2b on human liver cancer cells in vitro and in vivo , 2006 .

[5]  Y. Murawaki,et al.  Differential effects of interferon alpha-2b and beta on the signaling pathways in human liver cancer cells , 2005, Journal of Gastroenterology.

[6]  Yi Tang,et al.  Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. , 2005, Cancer research.

[7]  H. Eguchi,et al.  Combination of IFN-α and 5-Fluorouracil Induces Apoptosis through IFN-α/β Receptor in Human Hepatocellular Carcinoma Cells , 2005 .

[8]  H. Eguchi,et al.  Partial Contribution of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)/TRAIL Receptor Pathway to Antitumor Effects of Interferon-α/5-Fluorouracil against Hepatocellular Carcinoma , 2004, Clinical Cancer Research.

[9]  L. Qin,et al.  Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice , 2003, Journal of Gastrointestinal Surgery.

[10]  M. Chevallier,et al.  Long-term high-dose interferon-α therapy delays Hepadnavirus-related hepatocarcinogenesis in X/myc transgenic mice , 2003, Oncogene.

[11]  Y. Terashima,et al.  Genetic detection of liver micrometastases that are undetectable histologically. , 2002, The Journal of surgical research.

[12]  C. Carnovale,et al.  The in vivo apoptotic effect of interferon alfa‐2b on rat preneoplastic liver involves Bax protein , 2002, Hepatology.

[13]  S. Fan,et al.  Improving Survival Results After Resection of Hepatocellular Carcinoma: A Prospective Study of 377 Patients Over 10 Years , 2001, Annals of surgery.

[14]  G. Giannelli,et al.  Human Hepatocellular Carcinoma (HCC) Cells Require Both α3β1 Integrin and Matrix Metalloproteinases Activity for Migration and Invasion , 2001, Laboratory Investigation.

[15]  H. Yoshiji,et al.  The vascular endothelial growth factor receptor KDR/Flk‐1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model , 2001, Hepatology.

[16]  J. Miyazaki,et al.  Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. , 2001, Cancer research.

[17]  Y. N. Park,et al.  Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. , 2000, Archives of pathology & laboratory medicine.

[18]  K. Endo,et al.  Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival. , 2000, Human pathology.

[19]  T. Veikkola,et al.  Regulation of angiogenesis via vascular endothelial growth factor receptors. , 2000, Cancer research.

[20]  J. Bruix,et al.  Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma , 2000, Hepatology.

[21]  N. Prats,et al.  Expression of E-selectin, P-selectin, and intercellular adhesion molecule-1 during experimental murine listeriosis. , 1999, The American journal of pathology.

[22]  T. Nabika,et al.  Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver , 1998, Hepatology.

[23]  P. Matarrese,et al.  Antiproliferative activity of interferon α and retinoic acid in SiHa carcinoma cells: The role of cell adhesion , 1998, International journal of cancer.

[24]  N. Shinkura,et al.  Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. , 1998, Annals of surgery.

[25]  J. Folkman.  Clinical Applications of Research on Angiogenesis , 1995 .

[26]  J. Isner,et al.  Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. , 1995, Circulation.

[27]  A. Chow,et al.  Recombinant interferon‐α in inoperable hepatocellular carcinoma: A randomized controlled trial , 1993 .

[28]  H. Dvorak,et al.  Vascular Permeability Factor, Fibrin, and the Pathogenesis of Tumor Stroma Formation a , 1992, Annals of the New York Academy of Sciences.

[29]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[30]  S. Paget.  The distribution of secondary growths in cancer of the breast. 1889. , 1989, Cancer metastasis reviews.

[31]  Y Iwamoto,et al.  A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.

[32]  J. Fiddes,et al.  Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth , 1987, Nature.

[33]  Liotta La.  Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. , 1984, The American journal of pathology.

[34]  I. Fidler,et al.  The pathogenesis of cancer metastasis , 1980, Nature.

[35]  Y. Takeda,et al.  Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro. , 2007, Journal of hepatology.

[36]  S. Morinaga,et al.  Angiogenesis in hepatocellular carcinoma as evaluated by alpha smooth muscle actin immunohistochemistry. , 2001, Hepato-gastroenterology.

[37]  Jun Chen,et al.  Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1 , 1999, Journal of Cancer Research and Clinical Oncology.

[38]  J. Bingham.  Letter: Lower oesophageal sphincter. , 1974, Lancet.